{"doi":"10.4103/ijn.ijn_345_22","title":"Successful Reversal of Refractory Posttransplant Thrombotic Microangiopathy with Eculizumab","abstract":"<jats:p>Posttransplant thrombotic microangiopathy (PT-TMA) can be caused by calcineurin inhibitors (CNIs), ischemic injury, infections, or antibody-mediated rejection (ABMR). Delayed recognition can result in allograft loss. We describe the first reported case of successful reversal of refractory PT-TMA with eculizumab in India. It highlights the importance of prompt diagnosis and benefit from an early initiation of eculizumab therapy in refractory cases.</jats:p>","journal":"Indian Journal of Nephrology","year":2023,"id":630786,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1634351,"name":"Reetesh Sharma","orcid":null,"position":1,"is_corresponding":false},{"id":1028516,"name":"Saumya Gupta","orcid":"0009-0001-7904-9872","position":2,"is_corresponding":false},{"id":1634354,"name":"Sita Paikra","orcid":null,"position":3,"is_corresponding":false},{"id":1014911,"name":"Mohit Gupta","orcid":"0000-0002-2557-6212","position":4,"is_corresponding":false},{"id":1634358,"name":"Bal K. Upadhyay","orcid":null,"position":5,"is_corresponding":false},{"id":696736,"name":"Alok Sharma","orcid":"0000-0001-7014-4753","position":6,"is_corresponding":false},{"id":1634361,"name":"Rajiv K. Sethia","orcid":null,"position":7,"is_corresponding":false},{"id":1634350,"name":"Satish Chaudhary","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Successful Reversal of Refractory Posttransplant Thrombotic Microangiopathy with Eculizumab","abstract":"<jats:p>Posttransplant thrombotic microangiopathy (PT-TMA) can be caused by calcineurin inhibitors (CNIs), ischemic injury, infections, or antibody-mediated rejection (ABMR). Delayed recognition can result in allograft loss. We describe the first reported case of successful reversal of refractory PT-TMA with eculizumab in India. It highlights the importance of prompt diagnosis and benefit from an early initiation of eculizumab therapy in refractory cases.</jats:p>","is_dataset_classified":null,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"38681007","pmcid":"PMC11044662","openalex_id":"https://openalex.org/W4393325036","authors":[],"funders":[],"total_grants":0,"fwci":0.1962,"citation_percentile":0.5121225,"influential_citations":0,"citation_trend":[{"year":2025,"count":1}],"oa_status":"gold","license":"cc-by-nc-sa","oa_locations":[{"url":"https://doi.org/10.4103/ijn.ijn_345_22","host_type":"journal"},{"url":"https://doi.org/10.4103/ijn.ijn_345_22","host_type":"publisher"},{"url":"https://indianjnephrol.org/successful-reversal-of-refractory-posttransplant-thrombotic-microangiopathy-with-eculizumab/","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/38681007","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11044662","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11044662/pdf/IJN-34-2-191.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC11044662","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC11044662?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Renal Transplantation Outcomes and Treatments","Complement system in diseases","Transplantation: Methods and Outcomes"],"mesh_terms":[],"keywords":["Eculizumab","Thrombotic microangiopathy","Refractory (planetary science)","Medicine","Calcineurin","Internal medicine","Gastroenterology","Immunology","Antibody","Transplantation","Complement system","Biology","Disease","Refractory Posttransplant Tma"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Zero hunger"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-05T22:09:58.698282Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}